Flow Neuroscience Publishes Real-World Effectiveness Data for tDCS Depression Treatment
Summary
Flow Neuroscience published real-world effectiveness data from over 50,000 patients using its at-home tDCS device for depression. The data showed that patients reported significant improvements in depression symptoms after regular use of the device combined with the companion behavioral therapy app. The study also confirmed the favorable safety profile of home-based tDCS treatment.
Why it matters
Large real-world datasets complement controlled clinical trials by providing evidence of effectiveness in diverse, everyday use settings. With over 50,000 patients, this represents one of the largest real-world evaluations of tDCS for depression. The data support the potential for at-home neurostimulation to expand access to depression treatment, particularly in areas with limited mental health services.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial